Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
MACH7 TECHNOLOGIES LIMITED (M7T)ASX AI Signals has generated 0 signals for M7T during the last 90 days, indicating low trading activity
M7T Share Price | |
| Current Price | $0.295 |
| 52 Week High | $0.680 |
| 52 Week Low: | $0.255 |
| Trading at (% of 52 Week High) | 43.38% |
MACH7 Technologies Limited (ASX: M7T) provides enterprise imaging software solutions for healthcare organizations. The company’s platform helps streamline medical image management, improving access, sharing, and workflow efficiency in hospitals and clinics.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Key Insights
Given the large stake in the stock by institutions, Mach7 Technologies' stock price might be vulnerable to their trading decisions The top 5 shareholders own 53% of the company Past performance of a company along with ownership data serve to give a strong idea about prospects for a bus When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on the bright side, you can make far more than 100% on a really good stock. One great example is Mach7 Technologies Limited (ASX:M7T) which saw its share price drive 19 Key Insights
The projected fair value for Mach7 Technologies is AU$0.80 based on 2 Stage Free Cash Flow to Equity Mach7 Technologies' AU$0.53 share price signals that it might be 34% undervalued Mach7 Technologies' peers are currently trading at a premium of 140% on average
Today we'll do a simple With a median price-to-sales (or "P/S") ratio of close to 5.2x in the Healthcare Services industry in Australia, you could be forgiven for feeling indifferent about Mach7 Technologies Limited's (ASX:M7T) P/S ratio, which comes in at about the same. However, investors might be overlooking a clear op Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done Latest MACH7 TECHNOLOGIES LIMITED(M7T) News
Mach7 Technologies Limited's (ASX:M7T) institutional investors lost 12% over the past week but have profited from longer-term gains
Mach7 Technologies' (ASX:M7T) investors will be pleased with their strong 190% return over the last five years
Mach7 Technologies Limited's (ASX:M7T) Intrinsic Value Is Potentially 52% Above Its Share Price
Mach7 Technologies Limited's (ASX:M7T) Popularity With Investors Is Under Threat From Overpricing
Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial